Danaher earnings were $3.9B for the trailing 12 months ending Sep 27, 2024, with -34.1% growth year over year. The latest DHR earnings report on Sep 27, 2024 announced Q3 2024 earnings of $818.0M, down 9.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, DHR reported annual earnings of $4.7B, with -33.2% growth.
DHR past earnings growth
How has DHR's earnings growth performed historically?
On DHR's earnings call on Invalid Date, Danaher (NYSE: DHR) reported Q3 2024 earnings per share (EPS) of $1.13, up 26.14% year over year. Total DHR earnings for the quarter were $818.00 million. In the same quarter last year, Danaher's earnings per share (EPS) was $1.53.
As of the last Danaher earnings report, Danaher is currently profitable. Danaher's net profit (also called net income) for the twelve months ending Sep 27, 2024 was $3.89 billion, a 34.22% decrease year over year.
What was DHR's earnings growth in the past year?
As of Danaher's earnings date in Invalid Date, Danaher's earnings has grown -34.12% year over year. This is 27.58 percentage points lower than the US Diagnostics & Research industry earnings growth rate of -6.54%. DHR earnings in the past year totalled $3.89 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.